Riskpilot← Back to searchSign inGet full accessGOCE AS
ASActiveOrg 918848509Kanalveien 64, 5068 BergenMedical specialists activities · NACE 8622Est. 20171 employees
Revenue 2024
NOK 11,1M
+9% vs 2023
EBITDA margin
55.7%
+4% vs 2023
Equity ratio
85.9%
Financial strength
Net profit 2024
NOK 5,1M
+10% vs 2023
| Revenue | NOK 11,1M | +9% |
| EBITDA | NOK 6,2M | +4% |
| Net profit | NOK 5,1M | +10% |
| Total assets | NOK 24,4M | +21% |
| Equity | NOK 20,9M | +32% |
| Employees | 1 | — |
Legal name
GOCE AS
Org number
918848509
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
10. april 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive helsetjenester, kurs, utdanning, informasjon, forskning, publikasjon, salg, konulenttjenester, eie og forvalte fast eiendom, aksjer, obligasjoner og andre verdipapirer, deltagelse i andre selskaper, samt hva som står i forbindelse hermed.
Address
Kanalveien 64, 5068 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 545 | 9 706 | 10 548 | 10 174 | 11 059 |
| Staff expenses | −1 225 | −1 250 | −1 265 | −1 313 | −1 316 |
| EBITDA | 5 508 | 5 711 | 6 416 | 5 895 | 6 158 |
| Depreciation & amort. | −0 | −0 | −0 | −12 | −55 |
| EBIT | 5 508 | 5 711 | 6 416 | 5 883 | 6 103 |
| Net financials | 4 | 555 | −0 | −0 | 274 |
| Profit before tax | 5 512 | 6 267 | 6 416 | 5 883 | 6 378 |
| Tax | 1 216 | 1 384 | 1 414 | 1 302 | 1 318 |
| Net profit | 4 296 | 4 883 | 5 002 | 4 581 | 5 059 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 103 | 9 509 | 14 583 | 20 042 | 24 351 |
| Equity | 5 393 | 7 776 | 12 278 | 15 859 | 20 918 |
| Long-term debt | 0 | 0 | 0 | 1 672 | 1 928 |
| Short-term debt | 3 711 | 1 733 | 2 306 | 2 512 | 1 504 |
| Total debt | 3 711 | 1 733 | 2 306 | 4 183 | 3 433 |
EBITDA margin
55.7%
This company
15.8%
Market median
+253% vs market
20202024
Equity ratio
85.9%
This company
38.2%
Market median
+125% vs market
20202024
Return on equity
24.2%
This company
18.4%
Market median
+32% vs market
20202024
Net profit margin
45.7%
This company
8.1%
Market median
+464% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GOCE AS 
ODGAARD ASBoard members of GOCE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Georg Gjorgji Dimcevski | Chairman | 0 companies |